Non-interventional Study to Investigate Efficacy and Safety of Trabectedin (Yondelis) in Patients With Advanced Soft Tissue Sarcoma
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms YonSar
- Sponsors PharmaMar
- 27 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 27 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2018.
- 14 Sep 2015 According to a PharmaMar media release, data from this study will be presented at the 18th ECCO - 40th ESMO European Cancer Congress (ECC 2015).